New Search

If you are not happy with the results below please do another search

15 search results for:

1

Generative AI is set to transform medical affairs

/0 Comments/in
Generative AI is set to transform medical affairs' strategic approach to patient impact. Generative AI is a transformative force reshaping how we approach patient care in Pharma, Biotech, and Medtech. At FFI Ventures, we’re leading this change, empowering and accelerating Medical Affairs teams as they transition from strategy design to real-world use case implementation. We’re [...]
2

Continuous Evolution and Value-Add of Our Gen AI Agents

/0 Comments/in
Continuous Evolution and Value-Add of Our Gen AI Agents Our generative AI agents, or "bots" that we co-create with and implement in Pharma, Biotech & Medtech organizations are multi-talented, able to take on a wide range of business tasks and challenges. These agents are pre-trained and validated by domain experts before releasing to teams or [...]
3

Private generative AI is rapidly delivering value for Pharma

/0 Comments/in
Private generative AI is rapidly delivering value for Pharma As companies make progress with generative AI, they are increasingly capturing and delivering value. Specific examples in 2024 include Lilly, Sanofi, Pfizer, Roche, Boehringer Ingelheim, Novo Nordisk and aiCure). Generative AI has the potential to revolutionize the pharma and biotech industry. By applying this technology to [...]
4

How do companies get value out of AI in Medical Affairs?

/0 Comments/in
How do companies get value out of AI in Medical Affairs? With budget season upon most organizations, the questions about where to invest and how to deliver growth results or realize efficiencies are top of mind. Reflecting on 18 months with generative AI solutions and continued exchanges and discussions about yet more transformative potential of [...]
5

Early Diagnosis in Rare Diseases: The Power of Technology

/0 Comments/in
Early Diagnosis in Rare Diseases: The Power of Technology In the complex world of rare diseases, early diagnosis is both critical and challenging. With over 7,000 known rare diseases affecting millions worldwide, the need for innovative diagnostic approaches has never been greater. At FFI Ventures, we collaborate closely with life-science industry partners to leverage cutting-edge [...]
6

ONERAY.AI Capability Update: Document Summarization & Discussion

/0 Comments/in
ONERAY.AI capability update Exciting update! Our private Hashtag#generativeAI solution OneRay.AI, co-created with Pharma and Biotech partners just released a capability update. This state-of-the-art tool now offers ad-hoc summarization and discussion for up to 5 documents simultaneously in a secure, Pharma-compliant environment. It supports multiple formats, including images and graphs, and validates with Hashtag#Veeva and approved [...]
7

FFI generative AI framework & key services

/0 Comments/in
FFI generative AI framework & key services Ready to unlock the impact of #GenAI this summer? With over 18 months of diverse experience, FFI can rapidly support your organization in maximizing AI value creation. From strategy and governance to execution, we guide you through every step - including setting up your custom, private #GenerativeAI environment. [...]
8

FFI has a broad spectrum of capabilities

/0 Comments/in
FFI has broad spectrum of capabilities We're talking a lot about Hashtag#genAI but Hashtag#FFI goes beyond AI scaling in Pharma. We offer a unique blend of global and local expertise, combining innovative strategies with practical execution. Across Pharma, Medtech & Biotech functions, our approach and team delivers significant results & value-add. Discover how FFI can [...]
9

Ramping-up private gen AI within Pharma and Medtech organizations

/0 Comments/in
Ramping-up private gen AI within Pharma and Medtech organizations Especially for medical and commercial organizations, the integration of private bespoke generative AI solutions is becoming a game-changer. This blog post explores the strategic approach to implementing tailored AI solutions in the pharma industry, highlighting how FFI-Ventures can support organizations throughout this transformative journey. The step-wise [...]
10

Key Takeaways for Generative AI Adoption

/0 Comments/in
Key Takeaways for Gen AI Adoption With about 70 participants, the first Swiss AI Forum under the philosophy “from pharma for pharma” was a success and underlined the interest of Pharma and Biotech in tangible best practices to better achieve business objectives by applying generative AI solutions. For this occasion, the swiss health quality association [...]